Yu Shyr, Derek Shyr
研究成果: Editorial › 同行評審
}
TY - JOUR
T1 - What Constitutes a Valid Surrogate End Point in Cancer Clinical Trials?
AU - Shyr, Yu
AU - Shyr, Derek
PY - 2020/9
Y1 - 2020/9
UR - http://www.scopus.com/inward/record.url?scp=85091587762&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091587762&partnerID=8YFLogxK
U2 - 10.1001/jamaoncol.2020.1847
DO - 10.1001/jamaoncol.2020.1847
M3 - Editorial
C2 - 32701117
AN - SCOPUS:85091587762
SN - 2374-2437
VL - 6
SP - 1334
EP - 1335
JO - JAMA Oncology
JF - JAMA Oncology
IS - 9
ER -